Dr. Xiaochang Zhang's lab focuses on understanding how alterations in the SYNGAP1 gene contribute to neurodevelopmental disorders like autism. The researchers are investigating ways to correct the genetic malfunction by manipulating RNA splicing processes. By studying laboratory mice and human-derived neurons, they aim to develop innovative strategies that could potentially reverse the effects of genetic mutations associated with intellectual disabilities.

Dr. Savas Tay's lab at the University of Chicago focuses on how cells communicate and process information in complex environments. The lab combines experimental techniques with advanced technologies to analyze single cells, particularly in the context of immune signaling in health and disease. By understanding these processes, the research aims to improve therapies for various conditions, including cancer and autoimmune diseases.

Dr. S. Murray Sherman's lab at the University of Chicago focuses on the interactions between the thalamus and the cortex in the brain, specifically how these structures communicate to influence sensory processing and cognitive functions. The research aims to uncover the role of lesser-known thalamic nuclei in the flow of information across cortical areas, which could provide insights into cognitive disorders such as schizophrenia and Alzheimer's disease.

Dr. David Kovar's research lab at the University of Chicago focuses on studying the actin cytoskeleton, which is crucial for cell shape, movement, and division. By examining how cells organize various actin networks using a limited supply of actin proteins, the lab seeks to uncover the complex interactions that dictate the structure and function of these networks. The research employs model organisms like fission yeast and C. elegans to explore the molecular mechanisms governing self-organization of actin filaments important for cellular processes.

The research lab led by David Pincus at the University of Chicago focuses on understanding how cells adapt to changes in their environment over time. By studying various cellular responses, including how cells manage stress and alter their gene expression, the lab aims to uncover insights that could lead to new therapies for diseases like cancer and neurodegeneration. The research integrates molecular biology, genetics, and data science to develop predictive models of cellular behavior.

Dr. Alexander V. Chervonsky's lab focuses on understanding how sex differences and diet impact autoimmune diseases, particularly Type 1 diabetes (T1D). They study the role of hormones and gut microbes in disease mechanisms and are exploring dietary interventions that may help prevent or treat these conditions. By combining experimental models and advanced computational methods, the lab aims to identify new approaches to manage autoimmune diseases that disproportionately affect women.

Dr. Dominique Missiakas leads a research lab that focuses on developing new immune therapeutics, particularly monoclonal antibodies, to combat infections caused by Staphylococcus aureus, a serious human pathogen. The lab studies the mechanisms that bacteria use to evade the immune system and works on engineering antibodies to enhance their effectiveness. Additionally, the lab is involved in the management and application of BSL3 (Biosafety Level 3) lab practices to safely research emerging infectious diseases and bioterrorism threats.

Dr. Ronald S. Rock's lab studies how specific motor proteins called myosins move and function within cells. They focus on myosin-10, which plays a crucial role in delivering important molecules to areas of the cell that help it move, especially during cell division and in cancer metastasis. By understanding how these proteins are regulated and how they navigate within cells, the lab aims to shed light on fundamental biological processes and improve our understanding of cell movement in health and disease.

Dr. Nicholas G. Hatsopoulos leads a research lab at the University of Chicago focused on enhancing brain-computer interfaces (BCIs) to enable more dexterous control of robotic prosthetic limbs. The lab investigates how the brain encodes both hand movements and the forces exerted during tasks like grasping and transporting objects. By studying neural signals in the motor and somatosensory cortices, the team aims to develop advanced algorithms that improve the performance and feedback of brain-controlled prosthetics.

Dr. Jonathan P. Staley's lab focuses on understanding how genetic variations influence gene regulation and splicing in humans. They develop innovative methods to examine RNA splicing and its role in gene expression, aiming to uncover the biological significance of non-canonical splicing events. Their research has implications for understanding genetic contributions to complex traits and diseases.

Dr. Shabaana A. Khader's lab at the University of Chicago is focused on developing innovative vaccines against tuberculosis (TB). They study how certain immune responses can be enhanced to provide better protection against TB. The lab uses novel adjuvants to boost the immune system's Th1 and Th17 responses, aiming to create more effective vaccines that can tackle both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.

Dr. Joseph Thornton's lab at the University of Chicago focuses on understanding how proteins evolve and acquire new functions over time. Utilizing innovative techniques like ancestral protein reconstruction, the team examines the genetic and biochemical changes that lead to complex features in proteins, including their ability to interact in large complexes and respond to regulatory signals. Their research aims to reveal the historical pathways of protein evolution and how they can inform our understanding of health and disease.

Dr. Gregory A. Voth's lab focuses on using advanced computer simulations to better understand complex biological processes, specifically related to HIV-1 and cellular mechanics. By modeling how proteins interact with cell membranes and each other, the lab aims to uncover vital steps in the life cycle of the HIV virus and the mechanisms that allow cells to move and interact. This research has implications for developing new treatments for diseases related to HIV and cellular dysfunction.